We're Hiring!

We're Hiring!
linkedin instagram twitter

01Home

Open Sub Nav

Open Sub Nav

01Pipeline

01Our Team

01Investors & Media

01Careers

01Contact

Investors & Media

News

May 25, 2023

NGM Bio to Participate in Upcoming Investor Conferences

Learn More
→
May 8, 2023

NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023

Learn More
→
May 4, 2023

NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data

Learn More
→
March 1, 2023

NGM Bio to Participate in the Cowen 43rd Annual Health Care Conference

Learn More
→
February 28, 2023

NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2022 Financial Results

Learn More
→
January 12, 2023

NGM Bio to Participate in the B. Riley Securities 3rd Annual Oncology Conference

Learn More
→
January 9, 2023

NGM Bio Outlines Corporate Strategy and Provides Guidance on Key Priorities

Learn More
→

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com

Toolkit

RSS

RSS